Observational Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Sep 14, 2017; 23(34): 6294-6305
Published online Sep 14, 2017. doi: 10.3748/wjg.v23.i34.6294
Figure 1
Figure 1 Associations between availability, affordability, gross domestic product per capita and the uptake of biosimilars. Cz: The Czech Republic; Fr: France; D: Germany; Hu: Hungary; Lv: Latvia; Pl: Poland; Ro: Romania; Sk: Slovakia; Es: Spain; Se: Sweden; Prevalence: Patients on biologicals per 100000 population. GDP: Gross domestic product.